Lazard Research & Insights
September 22, 2025
Lazard Global Biopharmaceutical Leaders Study 2025
Biopharmaceutical and biotech investors ended the summer of 2025 amid heightened uncertainty and significant financial market pressures.
The Geopolitics of Biotech
A new report, The Geopolitics of Biotech, from Lazard’s Geopolitical Advisory team examines critical business, policy, and regulatory forces reshaping the global biotechnology sector today.
Lazard Technology Advisory | AI Impact on Technology M&A
AI is emerging as a once-in-a-generation investment opportunity, driving massive investment into AI-native businesses.
